Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $10.13 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 47.55.
Market Cap
10.13T
Revenue
4.74T
Profits
212.93B
PE Ratio
47.55
Profit Margin
4.49%
Dividend Yield
0.37%
1049 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | 4.56% | 1,741,223 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 679.66B | 2.21% | 3,179,675 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 518.65B | 0.72% | 2,635,882 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 366.48B | 1.32% | 3,137,376 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 356.54B | 0.95% | 2,496,814 | 450.06B |
| 6 | NVS | Novartis AG | 309.66B | 0.90% | 1,388,858 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 293.65B | 1.70% | 1,353,742 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 265.95B | 3.31% | 932,369 | 47.35B |
| 9 | AMGN | Amgen Inc. | 251.53B | 1.00% | 936,853 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 210.51B | 1.70% | 1,719,545 | 30.99B |
| 11 | ABT | Abbott Laboratories | 191.28B | 0.46% | 3,225,950 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 182.40B | 2.94% | 7,456,755 | 50.70B |
| 13 | PFE | Pfizer Inc. | 168.29B | 0.46% | 24,700,377 | 63.62B |
| 14 | DHR | Danaher Corporation | 165.75B | 2.32% | 1,685,637 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 159.84B | 1.83% | 1,173,243 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 139.81B | 0.79% | 491,571 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.94B | 0.72% | 3,707,580 | 50.03B |
| 18 | MDT | Medtronic plc | 126.55B | 1.55% | 3,003,412 | 37.54B |
| 19 | SYK | Stryker Corporation | 124.36B | 0.24% | 1,389,685 | 26.30B |
| 20 | MCK | McKesson Corporation | 122.54B | 0.05% | 220,115 | 418.79B |
| 21 | SNY | Sanofi | 115.10B | 2.90% | 3,678,499 | 57.89B |
| 22 | MRNA | Moderna, Inc. | 112.26B | 9.15% | 9,316,753 | 2.53B |
| 23 | CVS | CVS Health Corporation | 108.74B | 1.36% | 6,694,519 | 418.16B |
| 24 | HCA | HCA Healthcare, Inc. | 105.53B | 2.06% | 526,877 | 78.70B |
| 25 | GSK | GSK plc | 103.66B | 2.34% | 2,322,456 | 44.53B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 93.14B | 2.63% | 397,398 | 16.90B |
| 27 | ELV | Elevance Health, Inc. | 90.66B | -1.41% | 448,316 | 201.83B |
| 28 | CI | The Cigna Group | 77.72B | 0.46% | 914,572 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 67.66B | 0.50% | 1,566,071 | 29.86B |
| 30 | COR | Cencora, Inc. | 65.86B | 3.47% | 839,728 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 63.85B | 3.04% | 9,214,140 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 63.02B | 0.35% | 713,993 | 257.75B |
| 33 | EW | Edwards Lifesciences Corporation | 60.37B | 2.79% | 3,414,668 | 6.67B |
| 34 | ARGX | argenx SE | 59.07B | 3.84% | 301,856 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 58.84B | 1.95% | 997,104 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 55.78B | 4.73% | 362,044 | 4.66B |
| 37 | MDLN | Medline Inc. | 53.92B | 3.41% | 3,743,002 | 30.68B |
| 38 | HUM | Humana Inc. | 52.01B | -0.16% | 1,547,119 | 154.19B |
| 39 | A | Agilent Technologies, Inc. | 50.77B | 3.05% | 858,474 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 50.13B | 0.82% | 2,682,303 | 17.23B |
| 41 | VEEV | Veeva Systems Inc. | 49.75B | 1.17% | 608,178 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 47.81B | 2.84% | 342,190 | 6.45B |
| 43 | WAT | Waters Corporation | 46.82B | 4.13% | 490,111 | 5.61B |
| 44 | NTRA | Natera, Inc. | 46.39B | 2.97% | 1,762,398 | 2.91B |
| 45 | IQV | IQVIA Holdings Inc. | 46.00B | 2.67% | 556,726 | 17.31B |
| 46 | RVMD | Revolution Medicines, Inc. | 42.97B | 3.33% | 1,696,538 | 197.56M |
| 47 | RPRX | Royalty Pharma plc | 39.51B | 2.35% | 2,264,922 | 2.62B |
| 48 | HLN | Haleon plc | 39.02B | -2.02% | 11,888,909 | 14.80B |
| 49 | BIIB | Biogen Inc. | 38.20B | 4.05% | 597,181 | 10.30B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 38.15B | 2.42% | 2,321,056 | 21.64B |
| 51 | ALC | Alcon Inc. | 36.31B | 0.44% | 1,809,240 | 10.86B |
| 52 | GMAB | Genmab A/S | 35.71B | 2.83% | 2,875,124 | 4.30B |
| 53 | MTD | Mettler-Toledo International Inc. | 35.21B | 2.79% | 110,594 | 4.20B |
| 54 | CNC | Centene Corporation | 34.19B | -0.98% | 1,710,909 | 180.41B |
| 55 | ILMN | Illumina, Inc. | 33.66B | 4.46% | 1,026,849 | 4.54B |
| 56 | ZTS | Zoetis Inc. | 33.42B | 3.59% | 3,979,949 | 9.49B |
| 57 | RMD | ResMed Inc. | 33.26B | 0.49% | 606,721 | 5.73B |
| 58 | PHG | Koninklijke Philips N.V. | 30.31B | 1.75% | 1,112,062 | 20.16B |
| 59 | LH | Labcorp Holdings Inc. | 30.25B | 1.61% | 448,220 | 14.59B |
| 60 | DXCM | DexCom, Inc. | 30.24B | 2.09% | 1,967,000 | 5.10B |
| 61 | ROIV | Roivant Sciences Ltd. | 29.30B | 4.33% | 7,291,708 | 41.08M |
| 62 | WST | West Pharmaceutical Services, Inc. | 28.65B | 2.85% | 214,967 | 3.40B |
| 63 | DGX | Quest Diagnostics Incorporated | 28.51B | 1.37% | 493,395 | 11.84B |
| 64 | INSM | Insmed Incorporated | 25.23B | 0.51% | 1,467,510 | 1.52B |
| 65 | STE | STERIS plc | 25.06B | 2.28% | 503,133 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 24.93B | 4.15% | 197,865 | 3.19B |
| 67 | INCY | Incyte Corporation | 24.82B | 1.76% | 465,508 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.50B | 2.96% | 8,093,665 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 23.29B | 3.30% | 425,677 | 22.15B |
| 70 | BNTX | BioNTech SE | 22.00B | 1.41% | 580,807 | 2.75B |
| 71 | GH | Guardant Health, Inc. | 21.82B | 6.89% | 2,193,697 | 1.28B |
| 72 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.03B | 0.68% | 1,439,173 | 5.01B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 20.60B | 3.10% | 1,037,248 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.88B | 3.35% | 119,270 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 18.03B | 4.19% | 619,622 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 17.49B | 3.03% | 996,953 | 2.50B |
| 77 | CRL | Charles River Laboratories International, Inc. | 17.07B | 5.58% | 387,391 | 3.98B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 17.05B | 2.31% | 792,885 | 3.70B |
| 79 | ASND | Ascendis Pharma A/S | 16.87B | 0.04% | 342,750 | 1.20B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.60B | 3.55% | 415,627 | 4.72B |
| 81 | ICLR | ICON Public Limited Company | 15.58B | 1.61% | 490,296 | 8.23B |
| 82 | TEM | Tempus AI, Inc. | 15.56B | 12.16% | 5,330,696 | 1.51B |
| 83 | SOLV | Solventum Corporation | 15.39B | 0.33% | 617,163 | 8.16B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 15.13B | 4.58% | 1,504,429 | 945.54M |
| 85 | BTSG | BrightSpring Health Services, Inc. | 14.37B | 2.76% | 1,032,720 | 15.25B |
| 86 | SMMT | Summit Therapeutics Inc. | 14.32B | 9.68% | 4,682,159 | - |
| 87 | GKOS | Glaukos Corporation | 13.96B | 5.10% | 389,853 | 690.33M |
| 88 | EHC | Encompass Health Corporation | 13.80B | 2.22% | 664,070 | 6.34B |
| 89 | BAX | Baxter International Inc. | 13.70B | 2.69% | 2,128,459 | 11.61B |
| 90 | ELAN | Elanco Animal Health Incorporated | 13.54B | 5.21% | 4,354,901 | 5.15B |
| 91 | SNN | Smith & Nephew plc | 12.79B | -0.10% | 929,735 | 6.30B |
| 92 | PEN | Penumbra, Inc. | 12.66B | 0.59% | 112,736 | 1.56B |
| 93 | ALGN | Align Technology, Inc. | 12.43B | 6.20% | 1,213,745 | 4.16B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 12.37B | 0.80% | 1,522,226 | 3.44B |
| 95 | COO | The Cooper Companies, Inc. | 12.18B | 2.71% | 1,084,611 | 4.24B |
| 96 | FMS | Fresenius Medical Care AG | 12.02B | -1.67% | 642,673 | 22.12B |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.75B | -0.56% | 1,766,666 | 1.80B |
| 98 | DVA | DaVita Inc. | 11.68B | -2.97% | 318,015 | 14.17B |
| 99 | KYMR | Kymera Therapeutics, Inc. | 11.67B | 3.81% | 621,637 | 102.24M |
| 100 | TECH | Bio-Techne Corporation | 11.44B | 0.10% | 1,776,747 | 1.23B |
| 101 | RGEN | Repligen Corporation | 11.44B | 3.12% | 524,187 | 805.61M |
| 102 | UHS | Universal Health Services, Inc. | 11.38B | 0.98% | 304,820 | 18.35B |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 11.08B | 2.06% | 1,056,346 | 3.66B |
| 104 | AVTR | Avantor, Inc. | 10.77B | 2.75% | 4,437,573 | 6.64B |
| 105 | PCVX | Vaxcyte, Inc. | 10.66B | 5.35% | 542,065 | - |
| 106 | MOH | Molina Healthcare, Inc. | 10.62B | -2.49% | 260,678 | 42.08B |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 10.58B | 3.09% | 350,547 | 2.59B |
| 108 | ENSG | The Ensign Group, Inc. | 10.50B | 0.23% | 157,470 | 5.67B |
| 109 | QGEN | Qiagen N.V. | 10.45B | 0.53% | 3,382,646 | 2.12B |
| 110 | SYRE | Spyre Therapeutics, Inc. | 10.42B | 5.64% | 663,954 | - |
| 111 | PODD | Insulet Corporation | 10.39B | 2.27% | 692,247 | 3.19B |
| 112 | BRKR | Bruker Corporation | 10.19B | 8.82% | 1,626,544 | 3.51B |
| 113 | GMED | Globus Medical, Inc. | 10.08B | 7.07% | 2,025,408 | 3.14B |
| 114 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.00B | 7.76% | 314,193 | 1.43B |
| 115 | OSCR | Oscar Health, Inc. | 9.80B | 3.07% | 2,543,303 | 17.47B |
| 116 | HSIC | Henry Schein, Inc. | 9.75B | 2.51% | 592,027 | 13.73B |
| 117 | HNGE | Hinge Health, Inc. | 9.65B | 3.34% | 627,485 | 800.82M |
| 118 | ATR | AptarGroup, Inc. | 9.18B | 1.60% | 245,324 | 3.99B |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 9.04B | 16.67% | 726,124 | 7.46M |
| 120 | KRYS | Krystal Biotech, Inc. | 8.91B | -0.08% | 162,893 | 470.03M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 8.84B | 2.57% | 216,283 | 551.69M |
| 122 | TGTX | TG Therapeutics, Inc. | 8.70B | 2.52% | 2,717,297 | 897.76M |
| 123 | TWST | Twist Bioscience Corporation | 8.64B | 14.01% | 926,994 | 431.80M |
| 124 | TXG | 10x Genomics, Inc. | 8.57B | 9.97% | 1,674,964 | 618.58M |
| 125 | HQY | HealthEquity, Inc. | 8.43B | -1.61% | 414,191 | 1.36B |
| 126 | CORT | Corcept Therapeutics Incorporated | 8.29B | 4.15% | 1,010,434 | 963.65M |
| 127 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.95B | 2.08% | 544,645 | 280.75M |
| 128 | ALKS | Alkermes plc | 7.82B | 1.37% | 527,155 | 1.75B |
| 129 | PACS | PACS Group, Inc. | 7.77B | -1.28% | 618,239 | 5.71B |
| 130 | GRFS | Grifols, S.A. | 7.75B | 3.56% | 805,671 | 8.63B |
| 131 | ABVX | ABIVAX Société Anonyme | 7.75B | 2.08% | 431,948 | 5.33M |
| 132 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.74B | 5.00% | 372,798 | 945.96M |
| 133 | CYTK | Cytokinetics, Incorporated | 7.72B | 3.24% | 1,683,230 | 113.29M |
| 134 | IBRX | ImmunityBio, Inc. | 7.65B | -16.44% | 36,895,003 | 182.57M |
| 135 | BLCO | Bausch + Lomb Corporation | 7.41B | 3.70% | 439,793 | 5.42B |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 7.41B | 5.61% | 1,537,727 | 3.20B |
| 137 | CAI | Caris Life Sciences, Inc. | 7.34B | 1.47% | 2,176,997 | 1.05B |
| 138 | IMVT | Immunovant, Inc. | 7.11B | 12.74% | 2,469,741 | - |
| 139 | AXSM | Axsome Therapeutics, Inc. | 7.00B | 0.51% | 408,909 | 865.27M |
| 140 | CHE | Chemed Corporation | 6.99B | 2.12% | 84,763 | 2.66B |
| 141 | ORKA | Oruka Therapeutics, Inc. | 6.96B | 2.22% | 1,075,669 | - |
| 142 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.92B | -15.72% | 6,013,702 | 669.50M |
| 143 | CGON | CG Oncology, Inc. | 6.67B | -1.66% | 641,107 | 6.17M |
| 144 | KOD | Kodiak Sciences Inc. | 6.65B | 6.72% | 755,360 | - |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.61B | 0.43% | 362,524 | 1.56B |
| 146 | RDNT | RadNet, Inc. | 6.29B | 5.21% | 745,435 | 2.38B |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.29B | 2.72% | 69,708 | 253.83M |
| 148 | BLTE | Belite Bio, Inc | 6.28B | 1.18% | 162,247 | - |
| 149 | TFX | Teleflex Incorporated | 6.16B | 2.93% | 511,326 | 2.26B |
| 150 | SRRK | Scholar Rock Holding Corporation | 6.10B | 6.69% | 1,042,347 | - |
| 151 | MANE | Veradermics, Incorporated | 6.06B | 4.57% | 291,198 | - |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 6.01B | -1.71% | 341,572 | 670.78M |
| 153 | GRAL | GRAIL, Inc. | 5.92B | 8.34% | 407,455 | 166.60M |
| 154 | COGT | Cogent Biosciences, Inc. | 5.88B | 6.72% | 690,788 | - |
| 155 | DOCS | Doximity, Inc. | 5.83B | 0.43% | 1,336,960 | 661.58M |
| 156 | SUPN | Supernus, Inc. | 5.74B | 5.62% | 1,342,092 | 1.37B |
| 157 | LFST | LifeStance Health Group, Inc. | 5.63B | 7.55% | 19,381,544 | 1.68B |
| 158 | WAY | Waystar Holding Corp. | 5.60B | 2.61% | 411,189 | 1.26B |
| 159 | BLLN | BillionToOne, Inc. | 5.52B | 1.32% | 398,048 | 436.87M |
| 160 | HAE | Haemonetics Corporation | 5.47B | 0.22% | 485,403 | 1.38B |
| 161 | HIMS | Hims & Hers Health, Inc. | 5.46B | -10.04% | 28,927,880 | 2.58B |
| 162 | PTCT | PTC Therapeutics, Inc. | 5.46B | -0.21% | 272,594 | 1.16B |
| 163 | CON | Concentra Group Holdings Parent, Inc. | 5.40B | 1.04% | 578,465 | 2.34B |
| 164 | ERAS | Erasca, Inc. | 5.37B | 6.45% | 2,876,155 | - |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.34B | 2.22% | 168,485 | 1.61B |
| 166 | EWTX | Edgewise Therapeutics, Inc. | 5.15B | 4.40% | 1,348,386 | - |
| 167 | LIVN | LivaNova PLC | 5.12B | 3.19% | 188,235 | 1.51B |
| 168 | DNTH | Dianthus Therapeutics, Inc. | 5.11B | 5.44% | 407,685 | 2.72M |
| 169 | IONS | Ionis Pharmaceuticals, Inc. | 5.09B | -22.35% | 14,238,012 | 960.71M |
| 170 | MMED | MiniMed Group, Inc. | 4.98B | 5.86% | 2,534,955 | 3.22B |
| 171 | ADPT | Adaptive Biotechnologies Corporation | 4.96B | 9.47% | 1,600,551 | 298.01M |
| 172 | CRSP | CRISPR Therapeutics AG | 4.91B | 1.00% | 599,465 | 25.17M |
| 173 | HTFL | HeartFlow, Inc. | 4.90B | 7.47% | 958,252 | 212.07M |
| 174 | TVTX | Travere Therapeutics, Inc. | 4.89B | 2.68% | 464,010 | 651.03M |
| 175 | OPCH | Option Care Health, Inc. | 4.75B | 0.14% | 2,732,665 | 5.75B |
| 176 | DFTX | Definium Therapeutics, Inc. | 4.73B | 5.80% | 803,059 | - |
| 177 | SHC | Sotera Health Company | 4.72B | 3.19% | 949,018 | 1.23B |
| 178 | LEGN | Legend Biotech Corporation | 4.71B | 3.89% | 1,188,850 | 1.27B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.55B | 10.65% | 2,146,095 | 10.35M |
| 180 | ICUI | ICU Medical, Inc. | 4.51B | 4.76% | 146,989 | 2.18B |
| 181 | CDNA | CareDx, Inc. | 4.47B | 8.20% | 792,257 | 497.40M |
| 182 | ITGR | Integer Holdings Corporation | 4.31B | 0.06% | 353,330 | 1.83B |
| 183 | LQDA | Liquidia Corporation | 4.29B | 8.06% | 1,359,451 | 450.91M |
| 184 | PLSE | Pulse Biosciences, Inc. | 4.27B | 8.99% | 333,681 | 1.49M |
| 185 | NVST | Envista Holdings Corporation | 4.23B | 4.73% | 1,397,348 | 2.88B |
| 186 | ABCL | AbCellera Biologics Inc. | 4.11B | 6.65% | 2,038,480 | 66.17M |
| 187 | IOVA | Iovance Biotherapeutics, Inc. | 3.99B | 7.21% | 7,781,939 | 378.98M |
| 188 | XENE | Xenon Pharmaceuticals Inc. | 3.90B | 2.83% | 741,569 | 7.50M |
| 189 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.85B | 1.46% | 719,232 | -665.00K |
| 190 | WRBY | Warby Parker Inc. | 3.84B | 21.35% | 8,023,256 | 934.66M |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.84B | 5.91% | 1,243,463 | 53.81M |
| 192 | ELVN | Enliven Therapeutics, Inc. | 3.78B | 3.86% | 313,928 | - |
| 193 | STVN | Stevanato Group S.p.A. | 3.77B | 1.58% | 635,196 | 1.42B |
| 194 | PBLS | Parabilis Medicines, Inc. | 3.73B | 5.96% | 561,658 | 148.00K |
| 195 | VKTX | Viking Therapeutics, Inc. | 3.71B | 8.46% | 2,712,961 | - |
| 196 | IRON | Disc Medicine, Inc. | 3.69B | 2.56% | 379,484 | - |
| 197 | OGN | Organon & Co. | 3.64B | 0.11% | 1,710,129 | 6.10B |
| 198 | ACHC | Acadia Healthcare Company, Inc. | 3.59B | 4.41% | 1,462,427 | 3.41B |
| 199 | CELC | Celcuity Inc. | 3.54B | 7.80% | 440,154 | - |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.52B | 4.04% | 1,271,124 | - |
| 201 | TARS | Tarsus Pharmaceuticals, Inc. | 3.43B | 1.40% | 448,143 | 682.20M |
| 202 | SGRY | Surgery Partners, Inc. | 3.39B | 12.80% | 9,348,910 | 3.37B |
| 203 | VRDN | Viridian Therapeutics, Inc. | 3.39B | 4.84% | 2,260,855 | 26.31M |
| 204 | TLX | Telix Pharmaceuticals Limited | 3.37B | 3.12% | 287,785 | 890.79M |
| 205 | NHC | National HealthCare Corporation | 3.30B | 0.88% | 110,452 | 1.58B |
| 206 | TMDX | TransMedics Group, Inc. | 3.29B | 7.25% | 1,000,752 | 727.65M |
| 207 | DNLI | Denali Therapeutics Inc. | 3.26B | 1.40% | 636,148 | 21.38M |
| 208 | ACAD | Acadia Pharmaceuticals Inc. | 3.24B | -11.78% | 3,726,992 | 1.20B |
| 209 | ARQT | Arcutis Biotherapeutics, Inc. | 3.21B | -0.78% | 1,032,536 | 508.68M |
| 210 | BHC | Bausch Health Companies Inc. | 3.18B | 3.85% | 3,168,282 | 11.11B |
| 211 | PRVA | Privia Health Group, Inc. | 3.15B | 0.86% | 808,135 | 2.43B |
| 212 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | 2.02% | 345,619 | 36.54M |
| 213 | AXGN | Axogen, Inc. | 3.03B | 1.54% | 581,294 | 266.93M |
| 214 | IRTC | iRhythm Holdings, Inc. | 3.01B | -0.65% | 782,081 | 854.04M |
| 215 | VCEL | Vericel Corporation | 3.00B | 7.74% | 1,027,497 | 324.17M |
| 216 | ZLAB | Zai Lab Limited | 3.00B | 4.63% | 1,506,894 | 441.73M |
| 217 | XNCR | Xencor, Inc. | 2.97B | 10.71% | 822,199 | 200.49M |
| 218 | ATRC | AtriCure, Inc. | 2.97B | -0.50% | 422,730 | 589.80M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.90B | 8.09% | 446,499 | 1.46B |
| 220 | AVAH | Aveanna Healthcare Holdings Inc. | 2.90B | 0.26% | 804,019 | 2.60B |
| 221 | XERS | Xeris Biopharma Holdings, Inc. | 2.88B | 3.82% | 3,264,161 | 368.26M |
| 222 | ADMA | ADMA Biologics, Inc. | 2.88B | 1.89% | 1,916,837 | 519.15M |
| 223 | RGC | Regencell Bioscience Holdings Limited | 2.83B | 8.16% | 160,731 | - |
| 224 | BEAM | Beam Therapeutics Inc. | 2.72B | 3.29% | 578,959 | 146.64M |
| 225 | RCUS | Arcus Biosciences, Inc. | 2.72B | 3.23% | 388,585 | 100.00M |
| 226 | NEOG | Neogen Corporation | 2.66B | 3.49% | 1,504,740 | 884.00M |
| 227 | PGNY | Progyny, Inc. | 2.64B | 2.99% | 871,710 | 1.34B |
| 228 | CLOV | Clover Health Investments, Corp. | 2.64B | 2.28% | 6,414,331 | 2.74B |
| 229 | MBX | MBX Biosciences, Inc. | 2.60B | 5.06% | 266,855 | - |
| 230 | HCM | HUTCHMED (China) Limited | 2.58B | 0.96% | 41,270 | 549.12M |
| 231 | ARDT | Ardent Health, Inc. | 2.56B | 5.03% | 1,203,773 | 6.45B |
| 232 | PVLA | Palvella Therapeutics, Inc. | 2.54B | -1.34% | 192,598 | - |
| 233 | SDGR | Schrödinger, Inc. | 2.51B | 12.21% | 1,540,813 | 269.20M |
| 234 | UFPT | UFP Technologies, Inc. | 2.49B | 5.82% | 49,252 | 649.52M |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.46B | 4.82% | 981,681 | 158.00K |
| 236 | PHVS | Pharvaris N.V. | 2.41B | -0.32% | 333,225 | - |
| 237 | MD | Pediatrix Medical Group, Inc. | 2.39B | 0.45% | 192,951 | 1.96B |
| 238 | VIR | Vir Biotechnology, Inc. | 2.39B | 14.25% | 5,787,096 | 302.80M |
| 239 | RXRX | Recursion Pharmaceuticals, Inc. | 2.39B | 8.81% | 15,376,351 | 68.23M |
| 240 | IMNM | Immunome, Inc. | 2.33B | 5.56% | 661,449 | 4.02M |
| 241 | PRGO | Perrigo Company plc | 2.32B | 5.49% | 1,284,050 | 4.09B |
| 242 | SEPN | Septerna, Inc. | 2.32B | 1.66% | 359,326 | 98.88M |
| 243 | BHVN | Biohaven Ltd. | 2.32B | 5.94% | 1,929,960 | - |
| 244 | NEO | NeoGenomics, Inc. | 2.26B | 3.86% | 506,032 | 787.75M |
| 245 | ADUS | Addus HomeCare Corporation | 2.25B | -0.92% | 153,381 | 1.50B |
| 246 | VERA | Vera Therapeutics, Inc. | 2.22B | 3.31% | 922,808 | 10.28M |
| 247 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 0.43% | 385,898 | 321.74M |
| 248 | FTRE | Fortrea Holdings Inc. | 2.20B | 3.92% | 535,825 | 2.67B |
| 249 | BKD | Brookdale Senior Living Inc. | 2.19B | 1.78% | 6,421,364 | 2.86B |
| 250 | ALMR | Alamar Biosciences, Inc. | 2.19B | 12.37% | 406,605 | 114.05M |
| 251 | TRVI | Trevi Therapeutics, Inc. | 2.19B | 7.12% | 665,182 | - |
| 252 | ZYME | Zymeworks Inc. | 2.18B | 3.85% | 631,922 | 37.13M |
| 253 | LKFT | Lakefront Biotherapeutics NV | 2.18B | 1.94% | 231,951 | 1.13B |
| 254 | NAMS | NewAmsterdam Pharma Company N.V. | 2.18B | -3.81% | 943,478 | 25.94M |
| 255 | REPL | Replimune Group, Inc. | 2.12B | 3.52% | 1,790,563 | - |
| 256 | VCYT | Veracyte, Inc. | 2.10B | 7.62% | 2,873,148 | 581.78M |
| 257 | TRAX | First Tracks Biotherapeutics, Inc. | 2.10B | 4.22% | 311,583 | - |
| 258 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.09B | 7.05% | 1,011,875 | 213.00M |
| 259 | COAG | Hemab Therapeutics Holdings, Inc. | 2.09B | -8.65% | 685,720 | - |
| 260 | TRLV | Trulieve Cannabis Corp. | 2.08B | -6.49% | 1,275,993 | 1.08B |
| 261 | PBH | Prestige Consumer Healthcare Inc. | 2.06B | 0.88% | 251,625 | 1.17B |
| 262 | ESTA | Establishment Labs Holdings Inc. | 2.01B | 0.57% | 188,829 | 264.03M |
| 263 | ZBIO | Zenas BioPharma, Inc. | 2.00B | 4.28% | 244,574 | 11.00M |
| 264 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.99B | 0.39% | 1,676,184 | 961.51M |
| 265 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | 2.02% | 381,211 | 989.36M |
| 266 | WGS | GeneDx Holdings Corp. | 1.92B | 3.22% | 923,933 | 454.43M |
| 267 | AGL | agilon health, inc. | 1.92B | 0.63% | 98,556 | 6.00B |
| 268 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | -0.14% | 1,134,594 | 1.96B |
| 269 | CERT | Certara, Inc. | 1.90B | 3.49% | 2,841,327 | 425.76M |
| 270 | XRAY | DENTSPLY SIRONA Inc. | 1.89B | 1.06% | 3,437,186 | 3.58B |
| 271 | MAZE | Maze Therapeutics, Inc. | 1.88B | 2.11% | 291,777 | 20.00M |
| 272 | ABSI | Absci Corporation | 1.88B | 7.57% | 2,134,872 | 1.56M |
| 273 | AGIO | Agios Pharmaceuticals, Inc. | 1.87B | 6.36% | 547,053 | 140.84M |
| 274 | LMAT | LeMaitre Vascular, Inc. | 1.86B | 0.45% | 93,792 | 269.36M |
| 275 | MESO | Mesoblast Limited | 1.86B | 1.40% | 44,388 | 120.25M |
| 276 | INSP | Inspire Medical Systems, Inc. | 1.84B | -0.48% | 238,224 | 880.94M |
| 277 | NVAX | Novavax, Inc. | 1.84B | 3.20% | 6,028,189 | 411.65M |
| 278 | GENB | Generate Biomedicines, Inc. | 1.84B | 9.49% | 394,668 | 26.48M |
| 279 | KLRA | Kailera Therapeutics, Inc. | 1.82B | 8.02% | 670,923 | - |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.82B | 4.60% | 346,930 | 28.21M |
| 281 | ETON | Eton Pharmaceuticals, Inc. | 1.81B | 11.39% | 723,979 | 141.06M |
| 282 | KMTS | Kestra Medical Technologies, Ltd. | 1.80B | 4.83% | 156,899 | 106.73M |
| 283 | AZTA | Azenta, Inc. | 1.79B | 4.47% | 325,290 | 613.81M |
| 284 | BFLY | Butterfly Network, Inc. | 1.79B | 5.02% | 2,091,616 | 123.26M |
| 285 | SLS | SELLAS Life Sciences Group, Inc. | 1.78B | 4.63% | 3,277,782 | - |
| 286 | NRIX | Nurix Therapeutics, Inc. | 1.77B | 5.85% | 1,629,457 | 701.94M |
| 287 | OMCL | Omnicell, Inc. | 1.76B | 2.30% | 199,894 | 1.24B |
| 288 | LYCA | Lycia Therapeutics, Inc. | 1.75B | -0.39% | 106,241 | 4.44M |
| 289 | PGEN | Precigen, Inc. | 1.74B | 8.28% | 5,365,633 | 156.94M |
| 290 | PSNL | Personalis, Inc. | 1.73B | 0.98% | 1,496,880 | 80.77M |
| 291 | ALVO | Alvotech | 1.72B | -0.82% | 757,818 | 494.61M |
| 292 | ASTH | Astrana Health, Inc. | 1.71B | -2.93% | 394,030 | 3.91B |
| 293 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 6.08% | 1,944,510 | 52.89M |
| 294 | HCSG | Healthcare Services Group, Inc. | 1.68B | 2.76% | 231,277 | 1.88B |
| 295 | RARE | Ultragenyx Pharmaceutical Inc. | 1.66B | 5.57% | 1,414,621 | 730.00M |
| 296 | TDOC | Teladoc Health, Inc. | 1.65B | 3.31% | 2,287,973 | 2.47B |
| 297 | IMCR | Immunocore Holdings plc | 1.63B | 1.66% | 353,112 | 429.30M |
| 298 | ENOV | Enovis Corporation | 1.62B | 3.57% | 605,699 | 2.31B |
| 299 | SNDA | Sonida Senior Living, Inc. | 1.61B | 1.68% | 335,720 | 593.56M |
| 300 | NBTX | Nanobiotix S.A. | 1.61B | 5.03% | 134,031 | 13.15M |
| 301 | QURE | uniQure N.V. | 1.61B | 5.48% | 755,940 | 20.17M |
| 302 | BRVE | Braveheart Bio, Inc. | 1.58B | 4.19% | 422,949 | - |
| 303 | CNMD | CONMED Corporation | 1.55B | 1.22% | 133,855 | 1.37B |
| 304 | GPCR | Structure Therapeutics Inc. | 1.55B | 6.58% | 797,911 | - |
| 305 | NUVB | Nuvation Bio Inc. | 1.55B | 5.29% | 2,235,343 | 201.73M |
| 306 | TYRA | Tyra Biosciences, Inc. | 1.54B | 5.60% | 161,590 | - |
| 307 | ADRX | ADARx Pharmaceuticals, Inc. | 1.53B | 2.87% | 255,557 | 6.13M |
| 308 | ALHC | Alignment Healthcare, Inc. | 1.52B | -0.95% | 1,462,057 | 4.94B |
| 309 | DMRA | Damora Therapeutics, Inc. | 1.52B | 3.54% | 247,071 | - |
| 310 | RAPP | Rapport Therapeutics, Inc. | 1.51B | 4.01% | 440,169 | 20.00M |
| 311 | USPH | U.S. Physical Therapy, Inc. | 1.49B | 0.26% | 192,562 | 829.86M |
| 312 | OCUL | Ocular Therapeutix, Inc. | 1.48B | 1.90% | 2,332,642 | 50.38M |
| 313 | KARD | Kardigan, Inc. | 1.47B | 1.55% | 183,502 | - |
| 314 | NVCR | NovoCure Limited | 1.47B | -5.20% | 1,378,669 | 725.39M |
| 315 | LBRX | LB Pharmaceuticals Inc | 1.47B | 7.81% | 308,145 | - |
| 316 | PCRX | Pacira BioSciences, Inc. | 1.46B | 0.05% | 237,697 | 743.30M |
| 317 | AMN | AMN Healthcare Services, Inc. | 1.46B | 4.59% | 830,960 | 3.52B |
| 318 | ANAB | AnaptysBio, Inc. | 1.44B | 3.72% | 165,097 | 106.09M |
| 319 | TSHA | Taysha Gene Therapies, Inc. | 1.44B | 1.96% | 1,655,747 | 5.49M |
| 320 | ANIP | ANI Pharmaceuticals, Inc. | 1.44B | 0.55% | 151,055 | 1.04B |
| 321 | MLYS | Mineralys Therapeutics, Inc. | 1.43B | 5.28% | 1,776,410 | - |
| 322 | KRSA | Korsana Biosciences, Inc. | 1.41B | -0.43% | 52,147 | - |
| 323 | AAPG | Ascentage Pharma Group International | 1.41B | 0.45% | 4,111 | 94.61M |
| 324 | PAHC | Phibro Animal Health Corporation | 1.41B | 5.04% | 156,928 | 1.54B |
| 325 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 9.83% | 103,717 | 1.30M |
| 326 | MNKD | MannKind Corporation | 1.35B | 7.95% | 2,889,539 | 413.37M |
| 327 | INVA | Innoviva, Inc. | 1.35B | -0.42% | 1,009,372 | 438.32M |
| 328 | LMRI | Lumexa Imaging Holdings, Inc. | 1.34B | 3.57% | 167,779 | 1.04B |
| 329 | CRON | Cronos Group Inc. | 1.33B | - | 956,205 | 206.20M |
| 330 | GHRS | GH Research PLC | 1.32B | 3.65% | 127,205 | - |
| 331 | OPK | OPKO Health, Inc. | 1.31B | 2.31% | 1,738,321 | 654.10M |
| 332 | CMPS | COMPASS Pathways plc | 1.31B | 7.20% | 2,466,776 | - |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.31B | 3.13% | 326,256 | - |
| 334 | PNTG | The Pennant Group, Inc. | 1.30B | 2.15% | 281,033 | 1.17B |
| 335 | NUTX | Nutex Health Inc. | 1.30B | 5.31% | 97,709 | 796.53M |
| 336 | NKTR | Nektar Therapeutics | 1.30B | 2.39% | 325,119 | 54.59M |
| 337 | URGN | UroGen Pharma Ltd. | 1.29B | 5.98% | 753,244 | 250.25M |
| 338 | OMER | Omeros Corporation | 1.28B | 4.85% | 403,327 | 38.42M |
| 339 | PRCT | PROCEPT BioRobotics Corporation | 1.28B | 8.20% | 638,862 | 352.31M |
| 340 | AVLN | Avalyn Pharma Inc. | 1.28B | -1.20% | 413,314 | - |
| 341 | SVRA | Savara Inc. | 1.28B | 3.93% | 1,265,455 | - |
| 342 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | 7.45% | 1,564,189 | 1.08B |
| 343 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.26B | 3.90% | 340,400 | 745.79M |
| 344 | SGP | SpyGlass Pharma, Inc. | 1.26B | 1.66% | 113,604 | - |
| 345 | VOR | Vor Biopharma Inc. | 1.26B | 2.77% | 719,357 | - |
| 346 | INNV | InnovAge Holding Corp. | 1.25B | 1.90% | 142,107 | 1.02B |
| 347 | SLN | Silence Therapeutics plc | 1.23B | 0.13% | 1,161,837 | 615.00K |
| 348 | GDRX | GoodRx Holdings, Inc. | 1.23B | 2.56% | 504,176 | 785.23M |
| 349 | STAA | STAAR Surgical Company | 1.23B | -3.13% | 956,167 | 328.27M |
| 350 | SPTX | Seaport Therapeutics, Inc. | 1.21B | 5.16% | 174,234 | - |
| 351 | AHG | Akso Health Group | 1.19B | 2.96% | 6,352 | 13.83M |
| 352 | FRNM | Freenome, Inc. | 1.15B | 5.50% | 571,529 | 35.41M |
| 353 | SIBN | SI-BONE, Inc. | 1.15B | 5.49% | 879,009 | 220.65M |
| 354 | ATEC | Alphatec Holdings, Inc. | 1.13B | -1.75% | 2,190,575 | 839.72M |
| 355 | IRMD | IRADIMED CORPORATION | 1.12B | 1.12% | 41,545 | 89.34M |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.11B | 5.96% | 544,352 | 1.66B |
| 357 | ANRO | Alto Neuroscience, Inc. | 1.10B | 11.45% | 540,895 | - |
| 358 | VSTM | Verastem, Inc. | 1.10B | 3.69% | 1,353,965 | 100.30M |
| 359 | MLTX | MoonLake Immunotherapeutics | 1.08B | 10.23% | 963,960 | - |
| 360 | CBLL | CeriBell, Inc. | 1.06B | 2.86% | 181,801 | 108.72M |
| 361 | JBIO | Jade Biosciences, Inc. | 1.02B | 6.50% | 318,758 | - |
| 362 | AORT | Artivion, Inc. | 1.02B | 3.19% | 922,087 | 481.88M |
| 363 | CSTL | Castle Biosciences, Inc. | 1.02B | 1.51% | 159,279 | 377.13M |
| 364 | HROW | Harrow, Inc. | 1.01B | -0.11% | 515,604 | 275.59M |
| 365 | AHCO | AdaptHealth Corp. | 986.56M | 0.75% | 1,008,405 | 3.44B |
| 366 | PHAR | Pharming Group N.V. | 979.61M | 7.57% | 17,807 | 386.75M |
| 367 | CRVS | Corvus Pharmaceuticals, Inc. | 970.06M | 9.11% | 722,180 | - |
| 368 | ORIC | ORIC Pharmaceuticals, Inc. | 961.90M | 5.22% | 596,827 | - |
| 369 | OMDA | Omada Health, Inc. | 936.77M | 0.07% | 1,120,290 | 333.04M |
| 370 | ODTX | Odyssey Therapeutics, Inc. | 936.29M | 1.56% | 378,689 | 99.00K |
| 371 | BVS | Bioventus Inc. | 930.24M | 4.05% | 371,367 | 585.64M |
| 372 | BBNX | Beta Bionics, Inc. | 916.63M | 7.39% | 353,971 | 127.27M |
| 373 | MGTX | MeiraGTx Holdings plc | 910.49M | 5.33% | 294,555 | 397.50M |
| 374 | CTY | City Therapeutics, Inc. | 907.07M | -0.11% | 175,544 | 14.34M |
| 375 | IVA | Inventiva S.A. | 906.31M | 1.18% | 980,801 | 2.81M |
| 376 | GLUE | Monte Rosa Therapeutics, Inc. | 905.77M | 0.28% | 491,392 | 70.33M |
| 377 | AKTS | Aktis Oncology, Inc. | 897.14M | 1.96% | 263,521 | 10.06M |
| 378 | LTGO | Latigo Biotherapeutics, Inc. | 889.07M | 6.43% | 163,731 | - |
| 379 | IMTX | Immatics N.V. | 888.48M | 2.20% | 358,962 | 47.65M |
| 380 | HSTM | HealthStream, Inc. | 885.91M | 0.10% | 130,084 | 327.95M |
| 381 | KIDS | OrthoPediatrics Corp. | 882.53M | 6.42% | 293,007 | 264.14M |
| 382 | GMRS | GMR Solutions Inc. | 873.59M | -9.65% | 2,163,111 | 5.88B |
| 383 | SNDX | Syndax Pharmaceuticals, Inc. | 864.27M | 0.63% | 1,586,095 | 289.68M |
| 384 | DNA | Ginkgo Bioworks Holdings, Inc. | 851.85M | 12.05% | 2,246,829 | 130.75M |
| 385 | BBTX | Bambusa Therapeutics, Inc. | 848.19M | 5.85% | 215,856 | - |
| 386 | ALMS | Alumis Inc. | 846.51M | 8.46% | 1,175,969 | 7.40M |
| 387 | JANX | Janux Therapeutics, Inc. | 837.60M | -22.35% | 3,040,634 | 23.29M |
| 388 | LXRX | Lexicon Pharmaceuticals, Inc. | 828.14M | 4.49% | 1,569,396 | 38.54M |
| 389 | OBX | Obsidian Therapeutics, Inc. | 827.76M | -3.35% | 718,857 | - |
| 390 | ANNX | Annexon, Inc. | 811.40M | 1.90% | 1,827,745 | - |
| 391 | QDEL | QuidelOrtho Corporation | 809.97M | 10.33% | 2,380,236 | 2.59B |
| 392 | PHR | Phreesia, Inc. | 800.09M | 2.14% | 217,097 | 507.79M |
| 393 | SLDB | Solid Biosciences Inc. | 796.34M | 8.27% | 1,260,086 | - |
| 394 | RIGL | Rigel Pharmaceuticals, Inc. | 787.09M | 5.42% | 176,795 | 288.21M |
| 395 | AURA | Aura Biosciences, Inc. | 786.08M | 15.55% | 545,580 | - |
| 396 | PRME | Prime Medicine, Inc. | 785.45M | -5.05% | 2,511,856 | 4.07M |
| 397 | CGEM | Cullinan Therapeutics, Inc. | 784.48M | 7.78% | 443,068 | - |
| 398 | INMD | InMode Ltd. | 782.31M | 2.10% | 184,479 | 374.63M |
| 399 | IRWD | Ironwood Pharmaceuticals, Inc. | 778.09M | 7.06% | 3,846,901 | 400.30M |
| 400 | VREX | Varex Imaging Corporation | 777.84M | 0.08% | 160,290 | 865.00M |
| 401 | COLL | Collegium Pharmaceutical, Inc. | 774.71M | 2.97% | 318,724 | 815.19M |
| 402 | CTKB | Cytek Biosciences, Inc. | 774.24M | 1.54% | 916,850 | 207.65M |
| 403 | OABI | OmniAb, Inc. | 771.60M | 5.17% | 1,602,136 | 40.21M |
| 404 | SGMT | Sagimet Biosciences Inc. | 762.27M | 9.14% | 568,675 | - |
| 405 | ARDX | Ardelyx, Inc. | 749.09M | 3.47% | 3,959,099 | 468.22M |
| 406 | PACB | Pacific Biosciences of California, Inc. | 738.51M | 4.66% | 9,325,458 | 161.39M |
| 407 | ABUS | Arbutus Biopharma Corporation | 737.97M | 2.05% | 798,506 | 181.72M |
| 408 | NVCT | Nuvectis Pharma, Inc. | 736.27M | 2.39% | 235,361 | - |
| 409 | ATTO | Attovia Therapeutics, Inc. | 733.16M | 5.17% | 164,596 | 1.80M |
| 410 | CADL | Candel Therapeutics, Inc. | 731.52M | 9.26% | 1,056,261 | - |
| 411 | IMMX | Immix Biopharma, Inc. | 731.20M | 9.43% | 781,498 | - |
| 412 | ANL | Adlai Nortye Group Ltd. | 727.70M | 9.92% | 128,088 | 18.06M |
| 413 | SANA | Sana Biotechnology, Inc. | 725.12M | 2.11% | 1,878,722 | - |
| 414 | FLGT | Fulgent Genetics, Inc. | 721.11M | 8.72% | 472,132 | 330.28M |
| 415 | ZVRA | Zevra Therapeutics, Inc. | 714.06M | 3.54% | 1,007,430 | 147.76M |
| 416 | AVBP | ArriVent BioPharma, Inc. | 711.51M | 5.79% | 352,179 | - |
| 417 | ACHV | Achieve Life Sciences, Inc. | 693.56M | 0.30% | 607,764 | - |
| 418 | DSGN | Design Therapeutics, Inc. | 689.67M | 5.48% | 168,721 | - |
| 419 | WVE | Wave Life Sciences, Inc. | 689.32M | 3.86% | 2,547,130 | 70.92M |
| 420 | HELP | Helus Pharma Inc. | 688.96M | 5.25% | 1,006,152 | - |
| 421 | FDMT | 4D Molecular Therapeutics, Inc. | 688.34M | 1.71% | 332,150 | 92.01M |
| 422 | KURA | Kura Oncology, Inc. | 680.55M | 5.23% | 1,213,881 | 77.23M |
| 423 | DCTH | Delcath Systems, Inc. | 678.36M | 30.94% | 2,195,217 | 109.96M |
| 424 | APMD | Apnimed, Inc. | 674.00M | 7.22% | 163,478 | 115.12M |
| 425 | ACRS | Aclaris Therapeutics, Inc. | 668.55M | 8.08% | 1,110,608 | 6.40M |
| 426 | CLYM | Climb Bio, Inc. | 667.27M | 10.40% | 1,138,834 | - |
| 427 | DBVT | DBV Technologies S.A. | 666.74M | 6.03% | 339,059 | 3.74M |
| 428 | BCAX | Bicara Therapeutics Inc. | 656.44M | 14.68% | 1,162,255 | - |
| 429 | OLMA | Olema Pharmaceuticals, Inc. | 650.11M | 1.36% | 842,681 | - |
| 430 | SOPH | SOPHiA GENETICS SA | 640.72M | 4.76% | 215,461 | 90.97M |
| 431 | GERN | Geron Corporation | 639.86M | 0.34% | 3,493,233 | 217.52M |
| 432 | EVO | Evotec SE | 638.18M | 1.78% | 44,715 | 815.72M |
| 433 | IAM | Iambic Therapeutics, Inc. | 616.92M | 27.97% | 691,500 | 18.25M |
| 434 | CBIO | Crescent Biopharma, Inc. | 606.92M | 4.73% | 65,858 | 11.88M |
| 435 | SGHT | Sight Sciences, Inc. | 598.86M | 6.89% | 896,849 | 88.40M |
| 436 | TCMD | Tactile Systems Technology, Inc. | 596.32M | 2.27% | 89,265 | 356.42M |
| 437 | ENTX | Entera Bio Ltd. | 587.86M | 7.64% | 452,179 | 42.00K |
| 438 | AVR | Anteris Technologies Global Corp. | 583.01M | 5.10% | 341,675 | 2.24M |
| 439 | VALN | Valneva SE | 577.65M | 4.72% | 8,619 | 163.30M |
| 440 | OVID | Ovid Therapeutics Inc. | 569.29M | 2.28% | 3,324,801 | 1.58M |
| 441 | NRC | NRC Health | 566.40M | 3.21% | 24,431 | 143.79M |
| 442 | SRZN | Surrozen, Inc. | 563.61M | 3.92% | 55,399 | 11.51M |
| 443 | SLBT | SL Science Holding Limited | 562.11M | 5.14% | 8,937 | 3.27M |
| 444 | CAPR | Capricor Therapeutics, Inc. | 555.52M | 6.17% | 2,972,011 | 11.13M |
| 445 | MYGN | Myriad Genetics, Inc. | 551.55M | -2.87% | 1,144,715 | 803.60M |
| 446 | TKNO | Alpha Teknova, Inc. | 549.77M | 11.91% | 240,892 | 45.95M |
| 447 | RGNX | REGENXBIO Inc. | 542.21M | 7.61% | 690,590 | 153.91M |
| 448 | RCEL | AVITA Medical, Inc. | 541.22M | 5.49% | 640,717 | 84.68M |
| 449 | SRTA | Strata Critical Medical, Inc. | 534.13M | 7.55% | 1,108,030 | 280.76M |
| 450 | DMAC | DiaMedica Therapeutics Inc. | 528.20M | 4.65% | 74,750 | - |
| 451 | EVH | Evolent Health, Inc. | 527.07M | 1.75% | 1,302,889 | 2.34B |
| 452 | NGNE | Neurogene Inc. | 519.70M | 2.61% | 265,641 | 925.00K |
| 453 | ETRA | Electra Therapeutics, Inc. | 519.08M | 6.03% | 245,466 | - |
| 454 | SENS | Senseonics Holdings, Inc. | 517.11M | 13.85% | 531,020 | 48.55M |
| 455 | STTK | Shattuck Labs, Inc. | 510.23M | 8.44% | 507,676 | 1.00M |
| 456 | ANGO | AngioDynamics, Inc. | 509.70M | 3.32% | 337,229 | 325.38M |
| 457 | INDP | Indaptus Therapeutics, Inc. | 506.82M | -0.60% | 104,106 | - |
| 458 | MNPR | Monopar Therapeutics Inc. | 505.09M | 5.36% | 91,797 | - |
| 459 | MCTA | Charming Medical Limited | 504.26M | 6.75% | 4,251,392 | 4.81M |
| 460 | GYRE | Gyre Therapeutics, Inc. | 502.90M | -3.47% | 108,045 | 110.06M |
| 461 | EPRX | Eupraxia Pharmaceuticals Inc. | 491.50M | 8.27% | 429,868 | - |
| 462 | MDXG | MiMedx Group, Inc. | 489.58M | 1.36% | 516,967 | 303.73M |
| 463 | OCS | Oculis Holding AG | 489.54M | 5.87% | 197,474 | 1.12M |
| 464 | BLSM | BlossomHill Therapeutics, Inc. | 488.22M | 13.78% | 89,529 | - |
| 465 | YDES | YD Bio Limited | 487.32M | 15.24% | 26,505 | 1.24M |
| 466 | BWAY | BrainsWay Ltd. | 482.04M | 4.39% | 122,291 | 60.70M |
| 467 | MASS | 908 Devices Inc. | 480.71M | 10.13% | 172,188 | 60.84M |
| 468 | EOLS | Evolus, Inc. | 460.67M | 2.28% | 690,565 | 325.47M |
| 469 | NPCE | NeuroPace, Inc. | 455.14M | 6.08% | 165,271 | 106.99M |
| 470 | KMDA | Kamada Ltd. | 453.96M | 6.78% | 144,278 | 196.87M |
| 471 | AQST | Aquestive Therapeutics, Inc. | 453.73M | - | 2,445,706 | 48.84M |
| 472 | SI | Shoulder Innovations, Inc. | 452.76M | 5.36% | 157,546 | 64.49M |
| 473 | EDIT | Editas Medicine, Inc. | 446.92M | 13.23% | 1,853,483 | 49.83M |
| 474 | CTMX | CytomX Therapeutics, Inc. | 446.91M | -6.39% | 5,475,896 | 14.03M |
| 475 | OBIO | Orchestra BioMed Holdings, Inc. | 444.19M | 2.29% | 381,626 | 31.98M |
| 476 | RLMD | Relmada Therapeutics, Inc. | 443.75M | 6.67% | 524,576 | - |
| 477 | PRTA | Prothena Corporation plc | 441.86M | 7.97% | 362,815 | 52.74M |
| 478 | ARVN | Arvinas, Inc. | 440.06M | 4.84% | 507,837 | 275.30M |
| 479 | PBYI | Puma Biotechnology, Inc. | 439.80M | 3.27% | 461,166 | 231.87M |
| 480 | STLN | Starling Oncology, Inc. | 436.01M | 18.09% | 6,833,808 | 620.45M |
| 481 | RZLT | Rezolute, Inc. | 432.73M | 6.31% | 920,920 | - |
| 482 | TECX | Tectonic Therapeutic, Inc. | 427.94M | 6.06% | 63,566 | - |
| 483 | AVTX | Avalo Therapeutics, Inc. | 427.89M | 6.78% | 1,733,237 | 59.00K |
| 484 | ASMB | Assembly Biosciences, Inc. | 427.17M | 2.74% | 180,550 | 74.85M |
| 485 | CRMD | CorMedix Inc. | 426.36M | 2.82% | 1,322,152 | 462.25M |
| 486 | CARL | Carlsmed, Inc. | 426.20M | 7.51% | 96,625 | 63.30M |
| 487 | PHAT | Phathom Pharmaceuticals, Inc. | 424.95M | 1.90% | 738,943 | 274.88M |
| 488 | ALT | Altimmune, Inc. | 422.10M | 4.33% | 2,984,035 | 31.00K |
| 489 | TLRY | Tilray Brands, Inc. | 420.92M | -1.71% | 2,246,963 | 963.10M |
| 490 | CCCC | C4 Therapeutics, Inc. | 416.28M | 2.26% | 1,255,348 | 32.28M |
| 491 | CERS | Cerus Corporation | 416.03M | 1.98% | 1,359,174 | 226.57M |
| 492 | LYEL | Lyell Immunopharma, Inc. | 413.65M | 13.22% | 295,475 | 15.00K |
| 493 | MPLT | MapLight Therapeutics, Inc. | 413.48M | 7.36% | 268,871 | - |
| 494 | CTNM | Contineum Therapeutics, Inc. | 406.40M | 8.72% | 106,700 | - |
| 495 | CTEV | Claritev Corporation | 399.11M | 3.70% | 194,888 | 1.02B |
| 496 | PRLD | Prelude Therapeutics Incorporated | 394.47M | 6.39% | 111,538 | 22.42M |
| 497 | MOBI | Mobia Medical, Inc. | 386.94M | 3.75% | 103,652 | 51.89M |
| 498 | DTIL | Precision BioSciences, Inc. | 382.47M | -5.47% | 352,005 | 45.04M |
| 499 | SSII | SS Innovations International, Inc. | 380.73M | -9.95% | 143,949 | 52.40M |
| 500 | ALEC | Alector, Inc. | 379.64M | 11.35% | 1,548,864 | 173.47M |